LET’S TEST USING MOSQUITRIX VERSUS MALARIA
LET’S TEST USING MOSQUITRIX VERSUS MALARIA
Dear Mr. President: To my surprise, the carrier of the
malaria disease, the female Anopheles mosquito, is alive and well and living in
Palawan. The disease is caused by Plasmodium parasites that are spread through
the bites of infected Anopheles mosquitos. Once the parasites enter the
bloodstream, they travel to the liver, where they mature and multiply before infecting
the red blood cells.
Well, to be exact, the Anopheles mosquito could be also
living in other places of the Philippines, but Palawan is where 6,188 cases of malaria
were reported, out of the 6, 248 cases reported nationwide. Unfortunately,
there are no vaccines yet that are available for use against malaria in the
Philippines. The World Health Organization (WHO) has recommended the Mosquitrix
vaccine for Malaria prevention in children living in malaria-stricken regions in
the world, but up to now, these vaccines are used only in pilot programs in Africa.
As of now, Mosquitrix is not being used in the
Philippines yet, and there is no available information whether anyone, from the
government or the private sector has applied for approval from the Philippine
Food and Drug Administration (FDA). It seems logical to speculate that the most
likely applicant will be the local company of GlaxoSmithKline (GSK), since it
was GSK that developed the vaccine in collaboration with the PATH Malaria
Vaccine Initiative (MVI), with partial funding from the Bill and Melinda Gates
Foundation.
According to Microsoft Copilot, “the vaccine requires
at least three doses in infants by age 2, with a fourth dose extending protection
for another 1-2 years. It has been shown to reduce hospital admissions from
severe malaria by around 30% and toddler deaths by 15%”. Copilot also says that
“symptoms of malaria can include fever, chills, headache, nausea and muscle
pain. In severe cases, it can lead to complications like anemia, cerebral
malaria and organ failure”. Are these not enough reasons for us to plan and
already start pilot-testing Mosquitrix, preferably in Palawan?
Mr. President, we all have reason to believe that our
country is prone to diseases that are carried by mosquitos. Two of the best-known
diseases are malaria and dengue, but there could be more. It is still fresh in
our memory that we were totally caught unaware by the Covid 19 pandemic. As a
matter of fact, we had no choice but to use a vaccine that was not fully
tested, because we had to do it as a matter of survival. Fortunately, Sir, in
this case of malaria, there is a vaccine that has already been tested with good
results, and there is really nothing that stops us now from also start testing
it ourselves.
How and where do we start Sir? Perhaps with the local
offices of both GSK and Microsoft, because for sure they will be able to connect
us with their headquarters. Both the DFA and the DTI could also request our embassy
in Washington, DC because Microsoft is based in the US. Our embassy in London could talk to GSK, being based there in the UK. Other than
that, perhaps the DOH could coordinate with the local or regional offices of the
WHO, to start the ball rolling. IKE SENERES/11-05-2024
Comments
Post a Comment